Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice

Detalhes bibliográficos
Autor(a) principal: Chu Thi Thu Hien
Data de Publicação: 2023
Outros Autores: Phu Thi Hoa, Nguyen Hai Thuy, Tran Huu Dung
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/207608
Resumo: Resistant starch is particularly concerned with beneficial effects in regulating blood glucose concentration and lipid metabolism, reducing the risk of diabetes and cardiovascular diseases. This study aimed to validate the effects of wheat starch acetate containing 32.1% resistant starch on postprandial blood glucose response and lipid profile on obesity, dyslipidemia Swiss mice induced by a high-fat diet. The result showed that there was a restriction on postprandial hyperglycemia and remained stable for 2 hours after meal efficiently comparing with the control group fed natural wheat starch. Simultaneously, when maintaining the dose of 5g/kg once or twice a day for 8 weeks, wheat starch acetate to be able to reduce body weight and blood glucose, triglyceride, cholesterol levels compared to the control group (p<0.05).
id USP-31_731c50b50e58be6b003d1aa4840a603e
oai_identifier_str oai:revistas.usp.br:article/207608
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia miceAcetate wheat starchGlucoseLipidCholesterolResistant starch is particularly concerned with beneficial effects in regulating blood glucose concentration and lipid metabolism, reducing the risk of diabetes and cardiovascular diseases. This study aimed to validate the effects of wheat starch acetate containing 32.1% resistant starch on postprandial blood glucose response and lipid profile on obesity, dyslipidemia Swiss mice induced by a high-fat diet. The result showed that there was a restriction on postprandial hyperglycemia and remained stable for 2 hours after meal efficiently comparing with the control group fed natural wheat starch. Simultaneously, when maintaining the dose of 5g/kg once or twice a day for 8 weeks, wheat starch acetate to be able to reduce body weight and blood glucose, triglyceride, cholesterol levels compared to the control group (p<0.05).Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-02-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20760810.1590/s2175-97902022e20890Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/207608/197666Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessChu Thi Thu HienPhu Thi HoaNguyen Hai ThuyTran Huu Dung2023-08-30T19:27:37Zoai:revistas.usp.br:article/207608Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-30T19:27:37Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
title Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
spellingShingle Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
Chu Thi Thu Hien
Acetate wheat starch
Glucose
Lipid
Cholesterol
title_short Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
title_full Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
title_fullStr Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
title_full_unstemmed Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
title_sort Acetate wheat starch improving blood glucose response and bilan lipid on obesity dyslipidemia mice
author Chu Thi Thu Hien
author_facet Chu Thi Thu Hien
Phu Thi Hoa
Nguyen Hai Thuy
Tran Huu Dung
author_role author
author2 Phu Thi Hoa
Nguyen Hai Thuy
Tran Huu Dung
author2_role author
author
author
dc.contributor.author.fl_str_mv Chu Thi Thu Hien
Phu Thi Hoa
Nguyen Hai Thuy
Tran Huu Dung
dc.subject.por.fl_str_mv Acetate wheat starch
Glucose
Lipid
Cholesterol
topic Acetate wheat starch
Glucose
Lipid
Cholesterol
description Resistant starch is particularly concerned with beneficial effects in regulating blood glucose concentration and lipid metabolism, reducing the risk of diabetes and cardiovascular diseases. This study aimed to validate the effects of wheat starch acetate containing 32.1% resistant starch on postprandial blood glucose response and lipid profile on obesity, dyslipidemia Swiss mice induced by a high-fat diet. The result showed that there was a restriction on postprandial hyperglycemia and remained stable for 2 hours after meal efficiently comparing with the control group fed natural wheat starch. Simultaneously, when maintaining the dose of 5g/kg once or twice a day for 8 weeks, wheat starch acetate to be able to reduce body weight and blood glucose, triglyceride, cholesterol levels compared to the control group (p<0.05).
publishDate 2023
dc.date.none.fl_str_mv 2023-02-02
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/207608
10.1590/s2175-97902022e20890
url https://www.revistas.usp.br/bjps/article/view/207608
identifier_str_mv 10.1590/s2175-97902022e20890
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/207608/197666
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222917136482304